Scholarlink

Purpose <p>Uveal effusion syndrome (UES) is characterized by exudative detachments of choroid, ciliary body and retina. Like central serous chorioretinopathy (CSCR) it is associated with scleral thickening inhibiting fluid outflow. Recently, decreased levels of Lipocalin-2 (LCN2) and Pentraxin-3 (PTX3) were found in CSCR. The aim of this study was to measure these parameters in patients with UES to evaluate a possible pachychoroid continuum with UES as the maximum form.</p> Design <p>A randomized prospective case–control study was performed at the Ludwig Maximilians University, Department of Ophthalmology.</p> Methods <p>In patients with UES and in an age- BMI- and sex-matched control group, subfoveal choroidal thickness (SFCT) on optical coherence tomography imaging and the serum levels of PTX3 and LCN2 were measured.</p> Results <p>12 patients were included in each group. SFCT was significantly thicker in the UES group compared to the normal controls (<i>p</i> = 0.0003). LCN2 and PTX3 values tended to be lower in patients with UES (LCN2: 65.74 ± 33.81 (33.7 − 165.4) ng/ml vs. 108.8 ± 67.1 (40.8 − 261.9, <i>p</i> = 0.133) ng/ml PTX3: 0.82 ± 0.52 (0.13 − 2.1) ng/ml vs. 1.23 ± 0.77 (0.3 − 1.86, <i>p</i> = 0.260) ng/ml.</p> Conclusion <p>Lipocalin-2 and Pentraxin-3 values, which are known to be induced by glucocorticoids, tend to be lower in patients with UES. The results suggest an impairment in the glucocorticoid receptor pathway and underline the hypothesis of a common pathophysiological pathway of CSCR and UES.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pentraxin-3 and Lipocalin-2 are decreased in patients with uveal effusion syndrome

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月5日

查看全文
  • Caroline Havertz,
  • Benedikt Schworm,
  • Jakob Siedlecki,
  • Wolfgang Wilfert,
  • Bernd Northoff,
  • Siegfried G. Priglinger,
  • Leonie F. Keidel

摘要

Purpose

Uveal effusion syndrome (UES) is characterized by exudative detachments of choroid, ciliary body and retina. Like central serous chorioretinopathy (CSCR) it is associated with scleral thickening inhibiting fluid outflow. Recently, decreased levels of Lipocalin-2 (LCN2) and Pentraxin-3 (PTX3) were found in CSCR. The aim of this study was to measure these parameters in patients with UES to evaluate a possible pachychoroid continuum with UES as the maximum form.

Design

A randomized prospective case–control study was performed at the Ludwig Maximilians University, Department of Ophthalmology.

Methods

In patients with UES and in an age- BMI- and sex-matched control group, subfoveal choroidal thickness (SFCT) on optical coherence tomography imaging and the serum levels of PTX3 and LCN2 were measured.

Results

12 patients were included in each group. SFCT was significantly thicker in the UES group compared to the normal controls (p = 0.0003). LCN2 and PTX3 values tended to be lower in patients with UES (LCN2: 65.74 ± 33.81 (33.7 − 165.4) ng/ml vs. 108.8 ± 67.1 (40.8 − 261.9, p = 0.133) ng/ml PTX3: 0.82 ± 0.52 (0.13 − 2.1) ng/ml vs. 1.23 ± 0.77 (0.3 − 1.86, p = 0.260) ng/ml.

Conclusion

Lipocalin-2 and Pentraxin-3 values, which are known to be induced by glucocorticoids, tend to be lower in patients with UES. The results suggest an impairment in the glucocorticoid receptor pathway and underline the hypothesis of a common pathophysiological pathway of CSCR and UES.